Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports
Published in: Current Pulmonology Reports 1/2015

01-03-2015 | Pleural Diseases and Mesothelioma (G Lee, Section Editor)

IgG4-related pleural disease

Authors: Jay H. Ryu, Xiaowen Hu, Eunhee S. Yi

Published in: Current Pulmonology Reports | Issue 1/2015

Login to get access

Abstract

IgG4-related disease (IgG4-RD) is a newly recognized chronic systemic fibroinflammatory disease that displays protean manifestations. Since the initial description of IgG4-related pancreatitis (type 1 autoimmune pancreatitis), it has become clear that IgG4-RD can involve virtually any organ in the human body including intrathoracic structures. It is characterized by infiltration of IgG4-positive plasma cells and fibrosis in affected organs. IgG4-RD affects mainly adults, more commonly men. Most commonly described form of pulmonary involvement is focal parenchymal opacities. However, other forms of parenchymal involvement such as diffuse interstitial infiltrates have been reported as well as airway, vascular, mediastinal, and pleural disease. Pleural disease in IgG4-RD can present as pleural mass, pleuritis with fibrosis, or pleural effusion. IgG4-related pleural disease can present with or without concomitant parenchymal lung lesions or extrapulmonary manifestations of IgG4-RD. In patients presenting with fibroinflammatory disease involving the pleura of obscure cause, possible role of IgG-RD should be considered.
Literature
1.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8. see comment.CrossRefPubMed
2.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30.CrossRefPubMed
3.•
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51. This paper provides a broad overview of IgG4-RD.CrossRefPubMed
4.
Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–9.CrossRefPubMed
5.
6.
Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol. 2014;10(3):148–59.CrossRefPubMed
7.
Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annual Rev Pathol. 2014;9:315–47.CrossRef
8.
Takahashi H, Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Shinomura Y, et al. The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun. 2012;39(1–2):93–6.CrossRefPubMed
9.
Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):57–66.CrossRefPubMed
10.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1–14.CrossRefPubMedCentralPubMed
11.
Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33(12):1886–93.CrossRefPubMed
12.
Inoue D, Zen Y, Abo H, Gabata T, Demachi H, Kobayashi T, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009;251(1):260–70.CrossRefPubMed
13.•
Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J. 2012;39(1):180–6. This paper describes the spectrum of pleuropulmonary manifestations of IgG4-RD.CrossRefPubMed
14.
Shigemitsu H, Koss MN. IgG4-related interstitial lung disease: a new and evolving concept. Curr Opin Pulm Med. 2009;15(5):513–6.CrossRefPubMed
15.
Shrestha B, Sekiguchi H, Colby TV, Graziano P, Aubry M-C, Smyrk TC, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol. 2009;33(10):1450–62.CrossRefPubMed
16.
Matsui S, Hebisawa A, Sakai F, Yamamoto H, Terasaki Y, Kurihara Y, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013;18(3):480–7.CrossRefPubMed
17.
Taniguchi T, Ko M, Seko S, Nishida O, Inoue F, Kobayashi H, et al. Interstitial pneumonia associated with autoimmune pancreatitis [comment]. Gut. 2004;53(5):770. author reply 770–771.PubMedCentralPubMed
18.
Yamashita K, Haga H, Kobashi Y, Miyagawa-Hayashino A, Yoshizawa A, Manabe T. Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis: report of 3 cases and review of the literature. Am J Surg Pathol. 2008;32(11):1620–6.CrossRefPubMed
19.
Tanaka K, Nagata K, Tomii K, Imai Y. A case of isolated igg4-related interstitial pneumonia: a new consideration for the cause of idiopathic nonspecific interstitial pneumonia. Chest. 2012;142(1):228–30.CrossRefPubMed
20.
Umeda M, Fujikawa K, Origuchi T, Tsukada T, Kondo A, Tomari S, et al. A case of IgG4-related pulmonary disease with rapid improvement. Mod Rheumatol. 2012;22(6):919–23.CrossRefPubMed
21.
Yi ES, Sekiguchi H, Peikert T, Ryu JH, Colby TV. Pathologic manifestations of immunoglobulin(Ig)G4-related lung disease. Semin Diagn Pathol. 2012;29(4):219–25.CrossRefPubMed
22.
Ito S, Ko SBH, Morioka M, Imaizumi K, Kondo M, Mizuno N, et al. Three cases of bronchial asthma preceding IgG4-related autoimmune pancreatitis. Allergol Int. 2012;61(1):171–4.CrossRefPubMed
23.
Virk JS, Stamatoglou C, Kwame I, Salama A, Sandison A, Sandhu G. IgG4-sclerosing pseudotumor of the trachea: a case report and review of the literature. Arch Otolaryngol Head Neck Surg. 2012;138(9):864–6.CrossRefPubMed
24.
Sekiguchi H, Horie R, Aksamit TR, Yi ES, Ryu JH. Immunoglobulin G4-related disease mimicking asthma. Can Respir J. 2013;20(2):87–9.PubMedCentralPubMed
25.
Kobraei EM, Song TH, Mathisen DJ, Deshpande V, Mark EJ. Immunoglobulin g4-related disease presenting as an obstructing tracheal mass: consideration of surgical indications. Ann Thorac Surg. 2013;96(4):e91–3.CrossRefPubMed
26.
Shirai Y, Tamura Y, Yasuoka H, Satoh T, Kuwana M. IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment. Eur Respir J. 2014;43(5):1516–9.CrossRefPubMed
27.
Ishida M, Miyamura T, Sato S, Kimura D, Suematsu E. Pulmonary arterial hypertension associated with IgG4-related disease. Intern Med. 2014;53(5):493–7.CrossRefPubMed
28.
Inoue M, Nose N, Nishikawa H, Takahashi M, Zen Y, Kawaguchi M. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovasc Surg. 2007;55(10):431–3.CrossRefPubMed
29.
Ikeda K, Nomori H, Mori T, Kobayashi H, Iwatani K, Yoshimoto K, et al. Successful steroid treatment for fibrosing mediastinitis and sclerosing cervicitis. Ann Thorac Surg. 2007;83(3):1199–201.CrossRefPubMed
30.
Noh D, Park C-K, Kwon S-Y. Immunoglobulin G4-related sclerosing disease invading the trachea and superior vena cava in mediastinum. Eur J Cardiothorac Surg. 2014;45(3):573–5.CrossRefPubMed
31.
Yamamoto H, Suzuki T, Yasuo M, Kobayashi O, Tsushima K, Ito M, et al. IgG4-related pleural disease diagnosed by a re-evaluation of chronic bilateral pleuritis in a patient who experienced occasional acute left bacterial pleuritis. Intern Med. 2011;50(8):893–7.CrossRefPubMed
32.
Suzuki N, Saeki T, Shimaoka Y, Kuriyama H, Nishibori T, Ebe Y, et al. Two cases of IgG4-related disease with pleural effusion. Nihon Kokyuki Gakkai Zasshi. 2011;49(2):97–102.PubMed
33.
Sekiguchi H, Horie R, Utz JP, Ryu JH. IgG4-related systemic disease presenting with lung entrapment and constrictive pericarditis. Chest. 2012;142(3):781–3.CrossRefPubMed
34.
Kojima M, Nakazato Y, Kaneko Y, Sugihara S, Masawa N, Nakamura N. Cytological findings of IgG4-related pleural effusion: a case report. Cytopathology. 2013;24(5):338–40.PubMed
35.
Ishida A, Furuya N, Nishisaka T, Mineshita M, Miyazawa T. IgG4-related pleural disease presenting as a massive bilateral effusion. J Bronchology Interv Pulmonol. 2014;21(3):237–41.CrossRefPubMed
36.
Kato E, Takayanagi N, Ishiguro T, Kagiyama N, Shimizu Y, Sugita Y. IgG4-related pleuritis with chylothorax. Intern Med. 2014;53(14):1545–8.CrossRefPubMed
37.
Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, et al. Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz’s disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol. 2008;18(1):86–90.CrossRefPubMed
38.
Choi IH, Jang S-H, Lee S, Han J, Kim T-S, Chung M-P. A case report of IgG4-related disease clinically mimicking pleural mesothelioma. Tuber Respir Dis. 2014;76(1):42–5.CrossRef
39.••
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92. This paper outlines the current consensus histopathologic criteria in the diagnosis of IgG4-RD.CrossRefPubMed
40.
Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64(3):237–43.CrossRefPubMed
41.
Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44(11):2432–7.CrossRefPubMed
42.
Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23(1):108–13.CrossRefPubMed
43.
Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES. Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol. 2012;2012:232960.CrossRefPubMedCentralPubMed
44.
45.
Ngwa TN, Law R, Murray D, Chari ST. Serum immunoglobulin g4 level is a poor predictor of immunoglobulin g4-related disease. Pancreas. 2014;43(5):704–7.CrossRefPubMed
46.
Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(6):961–70.CrossRefPubMed
47.
Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):67–71.CrossRefPubMed
48.
Yamamoto M, Takahashi H, Ishigami K, Yajima H, Shimizu Y, Tabeya T, et al. Relapse patterns in IgG4-related disease. Ann Rheum Dis. 2012;71(10):1755.CrossRefPubMed
49.
50.
Naitoh I, Nakazawa T, Ohara H, Sano H, Ando T, Hayashi K, et al. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med. 2009;48(23):2003–7.CrossRefPubMed
51.
Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk. 2010;10(3):217–9.CrossRefPubMed
52.
Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91(1):57–66.CrossRefPubMed
53.
Sodikoff JB, Keilin SA, Cai Q, Bharmal SJ, Lewis MM, Raju GS, et al. Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis. World J Gastroenterol. 2012;18(18):2287–90.CrossRefPubMedCentralPubMed
54.
Murakami J, Matsui S, Ishizawa S, Arita K, Wada A, Miyazono T, et al. Recurrence of IgG4-related disease following treatment with rituximab. Mod Rheumatol. 2013;23(6):1226–30.CrossRefPubMed
55.
Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607–15.CrossRefPubMed
56.
Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56(12):1719–24.CrossRefPubMedCentralPubMed
57.
Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38(5):523–6.CrossRefPubMed
58.
Cheuk W, Yuen HKL, Chan ACL, Shih L-Y, Kuo T-T, Ma M-W, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(8):1159–67.CrossRefPubMed
59.
Hirano K, Tada M, Sasahira N, Isayama H, Mizuno S, Takagi K, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171–6.CrossRefPubMed
Metadata
Title
IgG4-related pleural disease
Authors
Jay H. Ryu
Xiaowen Hu
Eunhee S. Yi
Publication date
01-03-2015
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 1/2015
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-015-0105-9

Other articles of this Issue 1/2015

Current Pulmonology Reports 1/2015 Go to the issue

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Sleep-disordered breathing as a modifiable risk factor for cardiovascular disease

Pleural Diseases and Mesothelioma (C Gary Lee, Section Editor)

Adjunct strategies to enhance the efficacy of indwelling pleural catheters

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Sleep disorders in COPD

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Discovery of new biomarkers for malignant mesothelioma

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Chemical pleurodesis for first presentation of primary spontaneous pneumothorax

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Obesity hypoventilation syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits